Positive Airway Pressure Devices Market Size, Share, Growth, and Forecast 2025–2033

February 3, 2026

yash mishra

Market Overview:

According to IMARC Group’s latest research publication, “Positive Airway Pressure Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033“, The global positive airway pressure devices market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.14% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How AI is Reshaping the Future of Positive Airway Pressure Devices Market

Machine learning models are identifying cardiovascular disease risk in sleep apnea patients, with Mount Sinai researchers creating AI-powered prediction models that classify patients who may benefit most from treatment.
AI algorithms in modern CPAP devices like ResMed’s AirSense 11 feature auto-adjusting capabilities and integrated connectivity for personalized therapy adjustments and remote monitoring, improving patient adherence by 25%.
ResMed received FDA clearance for Smart Comfort, the first AI-enabled medical device that recommends personalized comfort settings using proprietary machine learning algorithms drawing on more than 100 million nights of real-world sleep data.
NovaResp’s cMAP software uses AI and machine learning to predict and prevent sleep apnea episodes before they occur, delivering personalized therapy at lower, more comfortable air pressure levels, with clinical trials showing improved REM and stable sleep while reducing mask leakage.
Wearable sensor technology combined with ML models helps clinicians predict, diagnose, and classify sleep apnea more accurately, reducing traditional polysomnography requirements and enabling home-based diagnosis with 85% accuracy rates.

Download a sample PDF of this report: https://www.imarcgroup.com/positive-airway-pressure-devices-market/requestsample

Key Trends in the Positive Airway Pressure Devices Market

Rising Sleep Apnea Awareness and Diagnosis: Growing awareness of sleep disorders is driving demand for diagnosis and treatment solutions. Philips launched new CPAP therapy devices in May 2024 specifically for sleep apnea treatment, with enhanced support systems including hotlines and dedicated websites, particularly expanding access in emerging markets like India. About 25 million adults in the U.S. suffer from obstructive sleep apnea, with an estimated 1 billion people affected globally.
Home Healthcare Revolution: With rising healthcare costs and emphasis on patient-centric care, more individuals are choosing home-based sleep apnea management. React Health’s Luna TravelPAP launched in March 2024 represents the trend toward portable, lightweight devices with CPAP and AutoCPAP modes for convenient home use. The home care segment is showing accelerated growth, with connected CPAP devices for home care holding over 68% share in the CPAP devices market in 2024.
Advanced Technology Integration: Continuous innovations enhance treatment efficacy through automatic pressure adjustment based on user needs. ResMed’s AirCurve 11 series, introduced in February 2024, features bilevel positive airway pressure technology designed to improve therapy initiation and adherence rates. In July 2024, Varon introduced its Sunnygrand series offering effective and comfortable treatment integrating with doctors’ prescribed settings.
Portable and Travel-Friendly Solutions: There is a notable shift toward compact and portable PAP devices catering to patients who travel frequently or desire less onerous options. In March 2024, React Health introduced the Luna TravelPAP, a compact, lightweight travel device with both CPAP and AutoCPAP modes, featuring supply reminders, light ring indicator, and an optional carrying case, maintaining therapeutic continuity while improving patient adherence.
Digital Health and Remote Monitoring: ResMed’s myAir app now integrates with Apple and Android smartwatches, allowing users to monitor therapy data at a glance and track sleep stages, with 87% of patients achieving therapy compliance. The integration of Bluetooth and smartphone connectivity allows for remote monitoring and data tracking, improving patient adherence and clinical outcomes.

Growth Factors in the Positive Airway Pressure Devices Market

Increasing Prevalence of Sleep Apnea: The rising prevalence of obstructive sleep apnea (OSA) among the masses across the globe is propelling market growth. According to the National Library of Medicine, approximately 3.9 million people in the United Kingdom were diagnosed with moderate to severe OSA as of January 2022. CPAP devices account for 67% of total device volume in 2024, supported by consistent clinical preference due to proven efficacy.
Favorable Reimbursement Policies: The wide availability of favorable reimbursement policies by government bodies is one of the key factors bolstering the market. Government schemes and insurance coverage are making PAP devices more accessible to patients, though high out-of-pocket costs remain a challenge with 34% of U.S. patients discontinuing PAP therapy within six months due to insurance barriers.
Growing Geriatric Population: Older adults are more susceptible to sleep apnea disorders, with a higher prevalence of obstructive sleep apnea linked to the reduction in upper airway lumen size that occurs with aging. The Congressional Budget Office projected that the population eligible for Social security will increase from 342 million in 2024 to 383 million by 2054.
Technological Advancements in Device Development: Companies like ResMed and Philips are introducing advanced features such as mobile app connectivity, improved comfort, quieter operation, and AI-enabled personalization. Innovations include auto-adjusting pressure settings, integrated humidifiers, and enhanced comfort features that improve patient compliance and drive adoption.
Expansion in Home Healthcare Solutions: With the inflating healthcare costs and the increasing emphasis on patient-centric care, more individuals are opting for home-based management of sleep apnea. This allows healthcare providers to monitor and adjust treatment remotely. The home care segment held 45% share in 2024, highlighting a significant shift from hospital-based treatment to remote therapy solutions.

The positive airway pressure devices market forecast offers insights into future opportunities and challenges, drawing on historical data and predictive modeling.

Leading Companies Operating in the Global Positive Airway Pressure Devices Industry:

3B Medical Inc.
Apex Medical Corp.
Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
Drive Devilbiss Healthcare (Drive International LLC)
Fisher & Paykel Healthcare Limited
Koninklijke Philips N.V.
Resmed Inc.
Smiths Group Plc
Somnetics International Inc.
Vyaire Medical Inc.

Positive Airway Pressure Devices Market Report Segmentation:

Breakup By Product Type:

Automatic Positive Airway Pressure (APAP) Devices
Continuous Positive Airway Pressure (CPAP) Devices
Bi-level Positive Airway Pressure (BiPAP) Devices

Continuous Positive Airway Pressure (CPAP) devices account for the majority of shares on account of their proven efficacy, widespread clinical acceptance, and cost-effectiveness.

Breakup By End User:

Hospitals and Sleep Labs
Home Care
Others

Hospitals and sleep labs dominate the market due to advanced diagnostic facilities and comprehensive treatment capabilities.

Breakup By Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

North America enjoys the leading position owing to a large market for positive airway pressure devices driven by rising prevalence of sleep disorders, advanced healthcare infrastructure, and increasing awareness about available treatment solutions.

Recent News and Developments in Positive Airway Pressure Devices Market

December 2024: ResMed received FDA clearance for Smart Comfort, the first AI-enabled medical device that recommends personalized comfort settings for CPAP therapy, with plans to launch in limited beta form in the U.S. in early 2026 via myAir app.
September 2024: ResMed unveiled new collection of digital and personalized solutions including generative AI-enabled sleep health assistant “Dawn” and integration of myAir consumer app with Apple and Android smartwatches to improve sleep health management.
July 2024: Varon introduced its new Sunnygrand series that offer effective and comfortable treatment for sleep apnea patients, integrating with doctors’ prescribed settings and therapy plans.
May 2024: Philips launched continuous positive airway pressure (CPAP) therapy devices for treating sleep apnea, offering support through a hotline and website, particularly expanding access in India.
May 2024: NovaResp raised $3 million in a seed extension round to support clinical testing of its cMAP positive airway pressure software that uses artificial intelligence to predict and prevent sleep apnea episodes.
March 2024: React Health developed a travel CPAP called the Luna TravelPAP, a small, lightweight positive airway pressure device with CPAP and AutoCPAP modes, supply reminders, an optional carrying case, and a light ring indicator.
February 2024: ResMed introduced its AirCurve 11 series bilevel positive airway pressure devices in the U.S., designed to help healthcare providers treat sleep apnea while improving patient therapy initiation and adherence rates.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.